scholarly article | Q13442814 |
P2093 | author name string | Ali N | |
Dey T | |||
Afrin F | |||
Anam K | |||
P2860 | cites work | Cell surface lipophosphoglycan of Leishmania donovani | Q69157660 |
Leishmania mexicana amazonensis: surface charge of amastigote and promastigote forms | Q71037111 | ||
Liposomal gene delivery: A complex package | Q73502164 | ||
Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins | Q73941136 | ||
Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical Studies | Q34234692 | ||
In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes | Q35311986 | ||
Sterically stabilized liposomes | Q35756716 | ||
Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years | Q38905579 | ||
Liposomal amphotericin B in drug-resistant visceral leishmaniasis | Q38963223 | ||
In Vitro Fusion of Reticulocyte Endocytic Vesicles with Liposomes | Q39473333 | ||
Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. | Q39830157 | ||
Antileishmanial activity of antimonials entrapped in liposomes | Q40131005 | ||
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis | Q40132280 | ||
Delivery of liposome-encapsulated drugs to macrophages | Q40167078 | ||
Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma | Q40696259 | ||
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus | Q40794338 | ||
Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes | Q41008898 | ||
Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells | Q41078793 | ||
Serum independent liposome uptake by mouse liver. | Q53746035 | ||
Leishmania donovani: Surface membrane carbohydrates of promastigotes | Q67010904 | ||
Trypanocidal activity of the stearylamine-bearing liposome in vitro | Q68156323 | ||
Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes | Q68811888 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 4 | |
P304 | page(s) | 1739-1742 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Antileishmanial activities of stearylamine-bearing liposomes | |
P478 | volume | 44 |
Q38914848 | Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity |
Q41678461 | Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani |
Q33982648 | Clinical and experimental advances in treatment of visceral leishmaniasis |
Q39955167 | Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice. |
Q42706310 | Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation |
Q35666558 | Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. |
Q37702257 | Drug delivery strategies for therapy of visceral leishmaniasis |
Q38254087 | Drug delivery: lessons to be learnt from Leishmania studies |
Q35101410 | Inhibition of the Growth of Plasmodium falciparum in Culture by Stearylamine-Phosphatidylcholine Liposomes. |
Q37128817 | Leishmaniasis treatment--a challenge that remains: a review |
Q43168913 | Liposomal formulations in the pharmacological treatment of leishmaniasis: a review. |
Q51767677 | Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis. |
Q37804399 | New delivery strategies for the old pentavalent antimonial drugs |
Q28477398 | Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice |
Q36887740 | Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major |
Search more.